Danish pharma giant Novo Nordisk (NVO) will make a significant investment of approximately $1.2 billion to construct a new production facility in Odense, Denmark. The new facility will focus on ...

The new plant will be one of the largest manufacturing investments in Novo Nordisk’s history and will add 1.4 million sq ft of production space for aseptic manufacturing and finished production ...

Novo Nordisk has started building its first brand-new manufacturing facility in Denmark since the millennium, saying it plans to spend around DKK 8.5 billion ($1.2 billion) on the plant.

Novavax NVAX announced that it has agreed to sell its manufacturing facility ... sale opportunities for the plant to save operating costs. If the deal with Novo Nordisk goes through, the company ...

It will boost the manufacturing capability for ... community and talented workforce,” he added. Novo Nordisk also plans to plant 4,000 new trees at the site in an effort to preserve local ...

Novo Holdings, the controlling shareholder of Novo Nordisk , hopes to double the size of its recently acquired contract ...

On Friday, however, Novo Nordisk announced top-line results in yet another trial. While the results don't initially sound as ...

Novo Holdings plans to double its newly acquired contract drugmaker, Catalent, within five years, focusing on U.S. manufacturing. The $16.5 billion acquisition is aimed at enhancing supply chains amid ...

Novo Nordisk could find its growth hampered even in the short term if it runs into complications at new production facilities. In addition, the company is facing scrutiny over its pricing ...